Companies / Indonesia
Novartis Opens Tropical Disease Research Institute
February 2007 | FDI AlertBranching out from its Singapore-based Novartis Institute of Tropical Diseases (NITD), the Swiss multinational has opened a scientific initiative in Indonesia to discover and develop treatments for neglected diseases. The company has teamed up with the Eijkman Institute and Hasanuddin University, which are both locally based, to form NEHCRI (the NITD - Eijkman Institute - Hasanuddin University Clinical Research Initiative). In addition to potentially finding cures for some of the world's deadliest infectious diseases, BMI welcomes this development as it will encourage development of a clinical trials industry in one of the world's most populated countries, enabling increased foreign direct
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
